T47.1
Poisoning by, adverse effect of and underdosing of other antacids and anti-gastric-secretion drugs
Clinical Classification Guidelines
Medical Intelligence & Overview
ICD-10 code T47.1 pertains to cases where individuals experience poisoning, adverse effects, or underdosing of medications used to reduce stomach acid. These drugs, including various antacids and anti-gastric-secretion medications, are commonly used to treat conditions like heartburn, acid reflux, and gastric ulcers. While generally safe when used appropriately, misuse or overuse can lead to health complications. This guide aims to provide an accessible overview of the causes, symptoms, diagnosis, and treatment considerations related to this condition.
Causes & Symptoms
Clinical Causes: Excessive self-medication without medical guidance Overuse or prolonged use of antacids and anti-gastric-secretion drugs Accidental overdose of medication Use of medications beyond recommended doses Combining multiple medications that contain similar active ingredients Incorrect administration methods
Key Symptoms: Nausea and vomiting Abdominal pain and discomfort Diarrhea or constipation Dizziness or lightheadedness Altered mental status in severe cases Electrolyte imbalances, such as hypocalcemia or hypokalemia Muscle weakness or cramps Signs of allergic reactions, like rash or swelling
Diagnostic & Treatment
Diagnosis Path: Diagnosing poisoning or adverse effects related to antacids involves a comprehensive medical evaluation. Healthcare providers typically review the patient's medication history and usage patterns. Diagnostic tests may include blood tests to identify electrolyte disturbances, kidney function tests, and possible toxicology screenings to detect excess levels of medication or related compounds. Imaging studies are rarely necessary but might be used to rule out other causes of gastrointestinal symptoms. Accurate diagnosis relies heavily on the patient's disclosure of medication use and symptom chronology.
Treatment Protocols: Managing poisoning or adverse effects from antacids and anti-gastric-secretion drugs involves several steps. Initial treatment focuses on stabilizing the patient, which may include supportive care like hydration and electrolyte correction. In cases of overdose, activated charcoal might be administered to reduce absorption. If specific symptoms or complications develop, targeted interventions are employed. For example, electrolyte imbalances are corrected with appropriate supplementation. Discontinuing or adjusting medication use under medical supervision is crucial to prevent recurrence. Severe cases may require hospitalization and specialized treatments, such as dialysis in instances of significant toxicity.
Clinical Advice & FAQs
Billing Guidance
Is T47.1 a billable ICD-10 code?
Yes, T47.1 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report T47.1?
Clinical documentation must specify the nature of Poisoning by, adverse effect of and underdosing of other antacids and anti-gastric-secretion drugs and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
